Jens-Peter Volkmer active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FORTY SEVEN, INC. | Founder | 2013-12-31 | - |
| Corporate Officer/Principal | 2013-12-31 | - | |
48 Bio, Inc.
 48 Bio, Inc. Pharmaceuticals: MajorHealth Technology 48 Bio, Inc. manufactures pharmaceutical and medicine. The CEO of the American company is Jens-Peter Volkmer. | Chief Executive Officer | - | - |
| Director of Finance/CFO | - | - |
Career history of Jens-Peter Volkmer
Statistics
International
| United States | 3 |
Operational
| Founder | 1 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
48 Bio, Inc.
48 Bio, Inc. Pharmaceuticals: MajorHealth Technology 48 Bio, Inc. manufactures pharmaceutical and medicine. The CEO of the American company is Jens-Peter Volkmer. | Health Technology |
- Stock Market
- Insiders
- Jens-Peter Volkmer
- Experience
